Cargando…
Extended-synaptotagmin 1 engages in unconventional protein secretion mediated via SEC22B(+) vesicle pathway in liver cancer
Protein secretion in cancer cells defines tumor survival and progression by orchestrating the microenvironment. Studies suggest the occurrence of active secretion of cytosolic proteins in liver cancer and their involvement in tumorigenesis. Here, we investigated the identification of extended-synapt...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457520/ https://www.ncbi.nlm.nih.gov/pubmed/36044553 http://dx.doi.org/10.1073/pnas.2202730119 |
_version_ | 1784786075571453952 |
---|---|
author | Yamada, Kohji Motohashi, Saya Oikawa, Tsunekazu Tago, Naoko Koizumi, Rei Ono, Masaya Tachibana, Toshiaki Yoshida, Ayano Yoshida, Saishu Shimoda, Masayuki Oka, Masahiro Yoneda, Yoshihiro Yoshida, Kiyotsugu |
author_facet | Yamada, Kohji Motohashi, Saya Oikawa, Tsunekazu Tago, Naoko Koizumi, Rei Ono, Masaya Tachibana, Toshiaki Yoshida, Ayano Yoshida, Saishu Shimoda, Masayuki Oka, Masahiro Yoneda, Yoshihiro Yoshida, Kiyotsugu |
author_sort | Yamada, Kohji |
collection | PubMed |
description | Protein secretion in cancer cells defines tumor survival and progression by orchestrating the microenvironment. Studies suggest the occurrence of active secretion of cytosolic proteins in liver cancer and their involvement in tumorigenesis. Here, we investigated the identification of extended-synaptotagmin 1 (E-Syt1), an endoplasmic reticulum (ER)-bound protein, as a key mediator for cytosolic protein secretion at the ER–plasma membrane (PM) contact sites. Cytosolic proteins interacted with E-Syt1 on the ER, and then localized spatially inside SEC22B(+) vesicles of liver cancer cells. Consequently, SEC22B on the vesicle tethered to the PM via Q-SNAREs (SNAP23, SNX3, and SNX4) for their secretion. Furthermore, inhibiting the interaction of protein kinase Cδ (PKCδ), a liver cancer-specific secretory cytosolic protein, with E-Syt1 by a PKCδ antibody, decreased in both PKCδ secretion and tumorigenicity. Results reveal the role of ER–PM contact sites in cytosolic protein secretion and provide a basis for ER-targeting therapy for liver cancer. |
format | Online Article Text |
id | pubmed-9457520 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | National Academy of Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-94575202023-03-03 Extended-synaptotagmin 1 engages in unconventional protein secretion mediated via SEC22B(+) vesicle pathway in liver cancer Yamada, Kohji Motohashi, Saya Oikawa, Tsunekazu Tago, Naoko Koizumi, Rei Ono, Masaya Tachibana, Toshiaki Yoshida, Ayano Yoshida, Saishu Shimoda, Masayuki Oka, Masahiro Yoneda, Yoshihiro Yoshida, Kiyotsugu Proc Natl Acad Sci U S A Biological Sciences Protein secretion in cancer cells defines tumor survival and progression by orchestrating the microenvironment. Studies suggest the occurrence of active secretion of cytosolic proteins in liver cancer and their involvement in tumorigenesis. Here, we investigated the identification of extended-synaptotagmin 1 (E-Syt1), an endoplasmic reticulum (ER)-bound protein, as a key mediator for cytosolic protein secretion at the ER–plasma membrane (PM) contact sites. Cytosolic proteins interacted with E-Syt1 on the ER, and then localized spatially inside SEC22B(+) vesicles of liver cancer cells. Consequently, SEC22B on the vesicle tethered to the PM via Q-SNAREs (SNAP23, SNX3, and SNX4) for their secretion. Furthermore, inhibiting the interaction of protein kinase Cδ (PKCδ), a liver cancer-specific secretory cytosolic protein, with E-Syt1 by a PKCδ antibody, decreased in both PKCδ secretion and tumorigenicity. Results reveal the role of ER–PM contact sites in cytosolic protein secretion and provide a basis for ER-targeting therapy for liver cancer. National Academy of Sciences 2022-08-31 2022-09-06 /pmc/articles/PMC9457520/ /pubmed/36044553 http://dx.doi.org/10.1073/pnas.2202730119 Text en Copyright © 2022 the Author(s). Published by PNAS. https://creativecommons.org/licenses/by-nc-nd/4.0/This article is distributed under Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Biological Sciences Yamada, Kohji Motohashi, Saya Oikawa, Tsunekazu Tago, Naoko Koizumi, Rei Ono, Masaya Tachibana, Toshiaki Yoshida, Ayano Yoshida, Saishu Shimoda, Masayuki Oka, Masahiro Yoneda, Yoshihiro Yoshida, Kiyotsugu Extended-synaptotagmin 1 engages in unconventional protein secretion mediated via SEC22B(+) vesicle pathway in liver cancer |
title | Extended-synaptotagmin 1 engages in unconventional protein secretion mediated via SEC22B(+) vesicle pathway in liver cancer |
title_full | Extended-synaptotagmin 1 engages in unconventional protein secretion mediated via SEC22B(+) vesicle pathway in liver cancer |
title_fullStr | Extended-synaptotagmin 1 engages in unconventional protein secretion mediated via SEC22B(+) vesicle pathway in liver cancer |
title_full_unstemmed | Extended-synaptotagmin 1 engages in unconventional protein secretion mediated via SEC22B(+) vesicle pathway in liver cancer |
title_short | Extended-synaptotagmin 1 engages in unconventional protein secretion mediated via SEC22B(+) vesicle pathway in liver cancer |
title_sort | extended-synaptotagmin 1 engages in unconventional protein secretion mediated via sec22b(+) vesicle pathway in liver cancer |
topic | Biological Sciences |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457520/ https://www.ncbi.nlm.nih.gov/pubmed/36044553 http://dx.doi.org/10.1073/pnas.2202730119 |
work_keys_str_mv | AT yamadakohji extendedsynaptotagmin1engagesinunconventionalproteinsecretionmediatedviasec22bvesiclepathwayinlivercancer AT motohashisaya extendedsynaptotagmin1engagesinunconventionalproteinsecretionmediatedviasec22bvesiclepathwayinlivercancer AT oikawatsunekazu extendedsynaptotagmin1engagesinunconventionalproteinsecretionmediatedviasec22bvesiclepathwayinlivercancer AT tagonaoko extendedsynaptotagmin1engagesinunconventionalproteinsecretionmediatedviasec22bvesiclepathwayinlivercancer AT koizumirei extendedsynaptotagmin1engagesinunconventionalproteinsecretionmediatedviasec22bvesiclepathwayinlivercancer AT onomasaya extendedsynaptotagmin1engagesinunconventionalproteinsecretionmediatedviasec22bvesiclepathwayinlivercancer AT tachibanatoshiaki extendedsynaptotagmin1engagesinunconventionalproteinsecretionmediatedviasec22bvesiclepathwayinlivercancer AT yoshidaayano extendedsynaptotagmin1engagesinunconventionalproteinsecretionmediatedviasec22bvesiclepathwayinlivercancer AT yoshidasaishu extendedsynaptotagmin1engagesinunconventionalproteinsecretionmediatedviasec22bvesiclepathwayinlivercancer AT shimodamasayuki extendedsynaptotagmin1engagesinunconventionalproteinsecretionmediatedviasec22bvesiclepathwayinlivercancer AT okamasahiro extendedsynaptotagmin1engagesinunconventionalproteinsecretionmediatedviasec22bvesiclepathwayinlivercancer AT yonedayoshihiro extendedsynaptotagmin1engagesinunconventionalproteinsecretionmediatedviasec22bvesiclepathwayinlivercancer AT yoshidakiyotsugu extendedsynaptotagmin1engagesinunconventionalproteinsecretionmediatedviasec22bvesiclepathwayinlivercancer |